Next Article in Journal
Evaluating Muscle Mass Changes in Critically Ill Patients: Rehabilitation Outcomes Measured by Ultrasound and Bioelectrical Impedance
Previous Article in Journal
Knowledge and Misinformation About Breast Cancer Risk Factors, Symptoms, and Prevention Among Healthy and Affected Women: A Study on 2375 Italian Participants
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 12
Issue 21
10.3390/healthcare12212127
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluating Patient Participation in Clinical Trials for CLL and SLE in Germany—A Mixed-Methods Study on Enrollment Potential Based on Claims Data

by
Ann-Sophie Kuschel
1,*,
Rianne Ernst
1,
Jan-Philipp Beck
1,
Kathrin Borchert
2,
Sebastian Braun
2,
Thorsten Ruppert
3 and
Matthias Meergans
3
1
Vintura GmbH, Münchner Technologiezentrum, Agnes-Pockels-Bogen 1, 80992 Munich, Germany
2
Xcenda GmbH, Lange Laube 31, 30159 Hannover, Germany
3
VFA (German Association of Research-Based Pharmaceutical Companies), 10117 Berlin, Germany
*
Author to whom correspondence should be addressed.
Healthcare 2024, 12(21), 2127; https://doi.org/10.3390/healthcare12212127
Submission received: 7 June 2024 / Revised: 10 October 2024 / Accepted: 21 October 2024 / Published: 25 October 2024
Browse Figures
Versions Notes

Abstract

Background: In recent years, the pharmaceutical industry in Germany has faced a significant decline in the number of clinical trials conducted. Methods: This study evaluates patient participation in clinical trials for oncology and chronic diseases in Germany, integrating quantitative and qualitative research. Data from the Institute for Applied Health Research Berlin (InGef (Institut für angewandte Gesundheitsforschung, Berlin, Germany)), covering about 88% of the German population, and expert interviews were used. Results: In 2022, 84.6% of 47,305 systemic lupus erythematosus patients (SLE) and 11.9% of 102,300 chronic lymphocytic leukemia patients (CLL) received guideline-based care based on study definitions. Eligibility for clinical trials between 2017 and 2022 was estimated for 8272 SLE and 886 CLL patients, with the actual enrolment of 21 of 2221 SLE patients and 86 of 340 CLL patients reflecting the respective potential. Conclusions: Findings indicate an unexploited potential to enroll patients with chronic diseases compared to the relatively higher enrolment rates observed for oncology diseases, such as CLL. Securing the continuation of clinical trials and utilizing the value of trial participation is of importance for strengthening Germany as an innovation hub and for ensuring that patients have timely access to medical innovations.
Keywords: Germany; pharmaceutical industry; clinical trials; healthcare; innovation; oncology; chronic diseases; statutory health insurance; InGef database Germany; pharmaceutical industry; clinical trials; healthcare; innovation; oncology; chronic diseases; statutory health insurance; InGef database

Share and Cite

MDPI and ACS Style

Kuschel, A.-S.; Ernst, R.; Beck, J.-P.; Borchert, K.; Braun, S.; Ruppert, T.; Meergans, M. Evaluating Patient Participation in Clinical Trials for CLL and SLE in Germany—A Mixed-Methods Study on Enrollment Potential Based on Claims Data. Healthcare 2024, 12, 2127. https://doi.org/10.3390/healthcare12212127

AMA Style

Kuschel A-S, Ernst R, Beck J-P, Borchert K, Braun S, Ruppert T, Meergans M. Evaluating Patient Participation in Clinical Trials for CLL and SLE in Germany—A Mixed-Methods Study on Enrollment Potential Based on Claims Data. Healthcare. 2024; 12(21):2127. https://doi.org/10.3390/healthcare12212127

Chicago/Turabian Style

Kuschel, Ann-Sophie, Rianne Ernst, Jan-Philipp Beck, Kathrin Borchert, Sebastian Braun, Thorsten Ruppert, and Matthias Meergans. 2024. "Evaluating Patient Participation in Clinical Trials for CLL and SLE in Germany—A Mixed-Methods Study on Enrollment Potential Based on Claims Data" Healthcare 12, no. 21: 2127. https://doi.org/10.3390/healthcare12212127

APA Style

Kuschel, A.-S., Ernst, R., Beck, J.-P., Borchert, K., Braun, S., Ruppert, T., & Meergans, M. (2024). Evaluating Patient Participation in Clinical Trials for CLL and SLE in Germany—A Mixed-Methods Study on Enrollment Potential Based on Claims Data. Healthcare, 12(21), 2127. https://doi.org/10.3390/healthcare12212127

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop